ALPORT SYNDROME FOUNDATION INC

EIN: 208237159 501(c)(3) Health Care

SCOTTSDALE, AZ

Total Revenue
$1,194,735
Total Expenses
$1,003,948
Total Assets
$2,817,931
Net Assets
$2,801,393
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2007
Legal Domicile
AZ
Principal Officer
DANIEL KILPATRICK
Phone
4808003510
Tax Period
2024-01-01 to 2024-12-31

ALPORT SYNDROME FOUNDATION INC, founded in 2007, is a community nonprofit in the Health Care sector that reported $1.2M in total revenue in fiscal year 2024. Revenue grew 18% year-over-year, indicating healthy expansion. The organization ran a surplus of $191K, a strong 16% operating margin.

Mission

THE FOUNDATION WAS CREATED TO EDUCATE AND SUPPORT PATIENTS AND FAMILIES THAT HAVE BEEN AFFECTED BY THIS GENETIC KIDNEY DISEASE WITH A GOAL OF FUNDING RESEARCH, TO FIND MORE EFFECTIVE TREATMENT PROTOCOLS AND TO ULTIMATELY FIND A CURE.

Program Service Accomplishments

Program 1
Expenses: $916,993

570 NEW MEMBERS JOINED ASF. 527 PATIENTS ENROLLED IN THE ASF ALPORT PATIENT REGISTRY. 800 NEW MEMBERS JOINED THE ASF FACEBOOK SUPPORT GROUP. 89,000 WEBSITE VIEWS. 18,000 ASF YOUTUBE CHANNEL VIEWS...

Read more

570 NEW MEMBERS JOINED ASF. 527 PATIENTS ENROLLED IN THE ASF ALPORT PATIENT REGISTRY. 800 NEW MEMBERS JOINED THE ASF FACEBOOK SUPPORT GROUP. 89,000 WEBSITE VIEWS. 18,000 ASF YOUTUBE CHANNEL VIEWS. HOSTED A 2-DAY IN-PERSON MEETING FOR 123 PATIENT/FAMILY MEMBERS, WITH PARTIAL FINANCIAL ASSISTANCE PROVIDED TO 57 INDIVIDUALS FOR TRAVEL. 200 HOURS OF STAFF TIME SPENT MEETING VIRTUALLY WITH PATIENTS/CAREGIVERS. HIRED A PART-TIME RESEARCH DIRECTOR TO SUPPORT THE PHARMACEUTICAL AND BIOTECH PIPELINE. FACILITATED 974 PATIENT VOLUNTEER HOURS AND 114 CLINICIAN VOLUNTEER HOURS. PARTNERED WITH ENYO PHARMACEUTICALS TO PROVIDE PATIENT INSIGHTS INTO CLINICAL TRIAL DESIGN AND TO SHARE INFORMATION ABOUT THE PHASE-2 ALPESTRIA-1 STUDY, WHICH FULLY ENROLLED AHEAD OF SCHEDULE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,063,256
Program Service Revenue $0
Investment Income $131,479
Other Revenue $0
TOTAL REVENUE $1,194,735

Expense Breakdown

Grants Paid $324,631
Salaries & Benefits $376,180
Fundraising Expenses $25,179
Program Expenses $916,993
Other Expenses $303,137
TOTAL EXPENSES $1,003,948

Year-over-Year Comparison

2024 2023 Change
Revenue $1,194,735 $1,016,405 +0.2%
Expenses $1,003,948 $612,534 +0.6%
Net Income $190,787 $403,871 -0.5%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
9
Independent Members
9
Employees
5
Volunteers
95

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
5
$105,000
Total Directors
9
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
LISA BONEBRAKE EXECUTIVE DIRECTOR 065.00
Officer
$105,000 $0 $105,000
ANDREW KRONENBERG BOARD CHAIR 010.00
Officer Director
$0 $0 $0
RYAN LINDER SECRETARY 002.50
Officer Director
$0 $0 $0
DANIEL KILPATRICK TREASURER 005.00
Officer Director
$0 $0 $0
SHARON LAGAS CO-FOUNDER, DIRECTOR PAST CHAIR 005.00
Officer Director
$0 $0 $0
AMY RHODES DIRECTOR 005.00
Director
$0 $0 $0
DECEMBER WEST DIRECTOR 001.00
Director
$0 $0 $0
MARTY DUNLEAVY DIRECTOR 001.00
Director
$0 $0 $0
PHILLIP KUMNICK DIRECTOR 001.00
Director
$0 $0 $0
STEPHEN MALACH DIRECTOR 001.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $1,194,735 $1,003,948 $2,817,931 $190,787
2023 $1,016,405 $612,534 $2,669,586 $403,871
2022 $990,673 $499,455 $2,277,966 $491,218
2021 $993,526 $478,020 $1,762,638 $515,506
2020 $738,552 $438,250 $1,307,819 $300,302
2019 $552,035 $656,048 $1,069,034 $-104,013
2018 $806,994 $693,773 $1,206,840 $113,221
Explore More Nonprofits
Top 100 Nonprofits in Arizona Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare ALPORT SYNDROME FOUNDATION INC with other nonprofits in Arizona and across the country.